Dennis Slamon, MD, PhD, professor and chief of hematology/oncology at the David Geffen School of Medicine at the University of California Los Angeles, and director of Clinical and Translational Research at the UCLA Health Jonsson Comprehensive Cancer Center, was elected to the Association of American Physicians.
Founded in 1885, the Association of American Physicians recognizes physician-scientists who have made contributions to biomedical research and academic medicine, according to an April 23 news release. Each year, the organization elects no more than 70 physicians whose work has had an impact on scientific discovery and patient care.
Dr. Slamon is known for research in breast cancer, including identifying the HER2 gene’s role in aggressive disease and leading development of targeted therapies. His work contributed to trastuzumab, a therapy for HER2-positive breast cancer, which accounts for 20% of the 1.7 million new breast cancer cases diagnosed worldwide each year.
Over a more than 40-year career at UCLA, Dr. Slamon has received multiple awards, including the 2019 Lasker-DeBakey Clinical Medical Research Award. In 2025, he was named to the National Academy of Inventors and was also recognized as one of Forbes’ 250 Greatest American Inventors.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.